Literature DB >> 8798006

New method for evaluation of perigastric invasion of gastric cancer by right lateral position CT.

T Shirakawa1, K Fukuda, S Tada.   

Abstract

The purpose of this study was to evaluate usefulness of right lateral position CT in determining invasion of gastric cancer into adjacent organs. We assessed whether position shift, a change in the relative location of a gastric tumor and adjacent organs between the supine position and right lateral position CT, was a useful sign for absence of invasion into perigastric organs. In 37 patients with advanced gastric cancer with doubtful invasion into adjacent organs by conventional CT after 500 ml water oral intake, additive right lateral CT was performed. Of 24 cases of lesions in the gastric body, 16 had a position shift and no invasion into adjacent organs at surgery (T3), and 8 had no position shift and invasion (T4). The accuracy was 100%. Six gastric cardial and 7 pyloric tumors showed no position shift, and 3 cardial and 2 pyloric tumors were proved to be noninvasive (T3). The accuracy of cardial and pyloric tumor was 50 and 71%. We concluded that position shift may be useful in the diagnosis of invasion of adjacent organs by gastric cancer, limited to in cases with gastric body cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8798006     DOI: 10.1007/bf00180611

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  9 in total

Review 1.  Technical principles in CT evaluation of the gut.

Authors:  V Raptopoulos
Journal:  Radiol Clin North Am       Date:  1989-07       Impact factor: 2.303

2.  Computed tomography of the stomach with water as an oral contrast agent: technique and preliminary results.

Authors:  A L Baert; L Roex; G Marchal; P Hermans; D Dewilde; G Wilms
Journal:  J Comput Assist Tomogr       Date:  1989 Jul-Aug       Impact factor: 1.826

3.  Use of water as an oral contrast agent for CT study of the stomach.

Authors:  G Angelelli; L Macarini; A Fratello
Journal:  AJR Am J Roentgenol       Date:  1987-11       Impact factor: 3.959

4.  Gastric adenocarcinoma: CT versus surgical staging.

Authors:  S K Sussman; R A Halvorsen; F F Illescas; R H Cohan; M Saeed; P M Silverman; W M Thompson; W C Meyers
Journal:  Radiology       Date:  1988-05       Impact factor: 11.105

5.  CT of gastric carcinoma: preliminary results with a new scanning technique.

Authors:  S Hori; K Tsuda; S Murayama; M Matsushita; K Yukawa; T Kozuka
Journal:  Radiographics       Date:  1992-03       Impact factor: 5.333

6.  Extraserosal invasion in advanced gastric cancer: evaluation with MR imaging.

Authors:  M Matsushita; H Oi; T Murakami; N Takata; T Kim; H Kishimoto; H Nakamura; S Okamoto; J Okamura
Journal:  Radiology       Date:  1994-07       Impact factor: 11.105

7.  Gastric tumors: radiologic-pathologic correlation and accuracy of T staging with dynamic CT.

Authors:  M Minami; N Kawauchi; Y Itai; T Niki; Y Sasaki
Journal:  Radiology       Date:  1992-10       Impact factor: 11.105

8.  Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT.

Authors:  J F Botet; C J Lightdale; A G Zauber; H Gerdes; S J Winawer; C Urmacher; M F Brennan
Journal:  Radiology       Date:  1991-11       Impact factor: 11.105

9.  Preoperative assessment of gastric carcinoma: value of two-phase dynamic CT with mechanical iv. injection of contrast material.

Authors:  J S Cho; J K Kim; S M Rho; H Y Lee; H Y Jeong; C S Lee
Journal:  AJR Am J Roentgenol       Date:  1994-07       Impact factor: 3.959

  9 in total
  2 in total

1.  Evaluation of contrast-enhanced helical hydro-CT in staging gastric cancer.

Authors:  Wen-Zhou Wei; Jie-Ping Yu; Jun Li; Chang-Sheng Liu; Xiao-Hua Zheng
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

2.  Preoperative T staging of gastric carcinoma obtained by MDCT vessel probe reconstructions and correlations with histological findings.

Authors:  M Moschetta; A A Stabile Ianora; A Anglani; A Marzullo; A Scardapane; G Angelelli
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.